Skip to main content

Table 1 Study schedule: treatment and data collection

From: Impact of treating chronic hepatitis C with direct acting antivirals on health-related quality of life: a real-life Egyptian experience

  1. BLUE highlighted sections are new as per this study; in GREY follows NTP standard procedure
  2. aWeek 12 corresponding EOT
  3. bWeek 24 corresponding to SVR12
  4. cWeek 36 corresponding to SVR12 after the end of treatment for those patients whose treatment course was 24 wks